UroGen Pharma Chief Medical Officer sells 5,222 shares for $143,000
UroGen Pharma Ltd.’s Chief Medical Officer sold 5,222 ordinary shares for a total of approximately $143,000.
The transaction was disclosed in a SEC Form 4 filing, with the shares sold at a weighted average price of $27.30.
This sale is part of a two-step process, where the Chief Medical Officer exercised 10,000 options and then immediately sold 5,222 shares for liquidity.
The remainder of the shares were held as ordinary shares, with the Chief Medical Officer reporting direct ownership of 139,763 shares after the sale.